Researchers at Fox Chase Cancer Center who looked at over 34,000 colorectal cancer patients found that certain PTEN mutations occur in distinct patterns in specific subsets of colorectal cancer.
Mainz Biomed, a molecular genetics diagnostic company specializing in the early detection of cancer, announced a collaborative agreement with Thermo Fisher Scientific Inc. through its subsidiary Life Technologies Corporation.
